chr10-49614173-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000466590.6(CHAT):​n.-17G>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00314 in 1,544,524 control chromosomes in the GnomAD database, including 145 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.016 ( 86 hom., cov: 28)
Exomes 𝑓: 0.0017 ( 59 hom. )

Consequence

CHAT
ENST00000466590.6 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.0340

Publications

1 publications found
Variant links:
Genes affected
CHAT (HGNC:1912): (choline O-acetyltransferase) This gene encodes an enzyme which catalyzes the biosynthesis of the neurotransmitter acetylcholine. This gene product is a characteristic feature of cholinergic neurons, and changes in these neurons may explain some of the symptoms of Alzheimer's disease. Polymorphisms in this gene have been associated with Alzheimer's disease and mild cognitive impairment. Mutations in this gene are associated with congenital myasthenic syndrome associated with episodic apnea. Multiple transcript variants encoding different isoforms have been found for this gene, and some of these variants have been shown to encode more than one isoform. [provided by RefSeq, May 2010]
CHAT Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 6
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • presynaptic congenital myasthenic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 10-49614173-G-A is Benign according to our data. Variant chr10-49614173-G-A is described in ClinVar as [Benign]. Clinvar id is 193434.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0547 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHATNM_020549.5 linkc.-17G>A 5_prime_UTR_variant Exon 1 of 15 ENST00000337653.7 NP_065574.4 P28329-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHATENST00000337653.7 linkc.-17G>A 5_prime_UTR_variant Exon 1 of 15 1 NM_020549.5 ENSP00000337103.2 P28329-1

Frequencies

GnomAD3 genomes
AF:
0.0162
AC:
2457
AN:
151526
Hom.:
84
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.0565
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00650
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000194
Gnomad SAS
AF:
0.000209
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000162
Gnomad OTH
AF:
0.0111
GnomAD2 exomes
AF:
0.00337
AC:
480
AN:
142228
AF XY:
0.00287
show subpopulations
Gnomad AFR exome
AF:
0.0608
Gnomad AMR exome
AF:
0.00308
Gnomad ASJ exome
AF:
0.000122
Gnomad EAS exome
AF:
0.000189
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000214
Gnomad OTH exome
AF:
0.00145
GnomAD4 exome
AF:
0.00172
AC:
2390
AN:
1392882
Hom.:
59
Cov.:
37
AF XY:
0.00148
AC XY:
1018
AN XY:
687072
show subpopulations
African (AFR)
AF:
0.0588
AC:
1852
AN:
31508
American (AMR)
AF:
0.00361
AC:
127
AN:
35200
Ashkenazi Jewish (ASJ)
AF:
0.0000398
AC:
1
AN:
25124
East Asian (EAS)
AF:
0.0000280
AC:
1
AN:
35718
South Asian (SAS)
AF:
0.000316
AC:
25
AN:
79108
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
47292
Middle Eastern (MID)
AF:
0.00267
AC:
11
AN:
4118
European-Non Finnish (NFE)
AF:
0.000129
AC:
139
AN:
1077094
Other (OTH)
AF:
0.00405
AC:
234
AN:
57720
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
118
236
353
471
589
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0163
AC:
2467
AN:
151642
Hom.:
86
Cov.:
28
AF XY:
0.0154
AC XY:
1141
AN XY:
74118
show subpopulations
African (AFR)
AF:
0.0566
AC:
2332
AN:
41204
American (AMR)
AF:
0.00649
AC:
99
AN:
15248
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5144
South Asian (SAS)
AF:
0.000210
AC:
1
AN:
4770
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10584
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000162
AC:
11
AN:
67926
Other (OTH)
AF:
0.0110
AC:
23
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
109
218
327
436
545
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00830
Hom.:
5
Bravo
AF:
0.0189
Asia WGS
AF:
0.00231
AC:
8
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 03, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Nov 23, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
2.5
DANN
Benign
0.82
PhyloP100
0.034
PromoterAI
-0.0088
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs77152496; hg19: chr10-50822219; API